Use of porcine trypsin used in the manufacture of human biological medicinal products

Current effective version

PDF iconAdopted guideline

Reference numberEMA/CHMP/BWP/814397/2011
Published28/02/2014
Effective from01/09/2014
KeywordsPorcine trypsin, adventitious agents, virus
DescriptionThis document covers the viral safety aspects of human biological medicinal products using porcine trypsin.


Document history

First version

Current version

PDF iconAdopted guideline


PDF iconOverview of comments


PDF iconDraft guideline


PDF iconConcept paper

In operation: 01/09/2014–present


Published: 04/03/2014


Published: 01/03/2013


Published: 20/11/2008


Related content


How useful was this page?

Add your rating